홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
March 1, 2026
Open Access
The dilemma after chimeric antigen receptor T-cell therapy – to transplant or not?
EJ
Elad Jacoby
BB
Bella Bielorai
Key Points
To examine the challenges and considerations involved in the decision to proceed with transplantation following chimeric antigen receptor T-cell therapy.
Review of clinical outcomes post-T-cell therapy
Analysis of transplant eligibility criteria
Evaluation of patient responses to therapy
Identified critical factors influencing transplant decisions
Noted varied patient outcomes after therapy
Highlighted the need for individualized treatment plans
Abstract
Not available.
Read Full Paper
with AI
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
Mark Helpful
Like
Save
Bookmark
Relay
Share
View Full Paper
The dilemma after chimeric antigen receptor T-cell therapy – to transplant or not? | Synapse
Cite This Study
Copy
Jacoby et al. (Thu,) studied this question.
synapsesocial.com/papers/69a3d747ec16d51705d2db5d
https://doi.org/https://doi.org/10.3324/haematol.2025.300318